Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 3019, Suchdauer: 1.27s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Droplet Helical Motion on Twisted Fibers

von Van Hulle, J. ; Delforge, C. ; Leonard, M. ; et al.

Langmuir. 40(48):25413-25419
- View full text at ACS Publications
Merkliste

2
Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician’s Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma

von Touzeau, Cyrille ; Lipe, Brea ; Khan, Abdullah M. ; et al.

Advances in Therapy. 42(10):5023-5041
- Zum Volltext (via ReDI)
Merkliste

3
Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe

von Abela, Irene A. ; Aebi-Popp, Karoline ; Anagnostopoulos, Alexia ; et al.

In JHEP Reports February 2026 8(2)
- View full text via DOI
Merkliste

4
Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations

von El-Sadr, W. ; Calvo, G. ; Bonnet, F. ; et al.

In eClinicalMedicine January 2026 91
- View full text via DOI
Merkliste

5
EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER 1–3 PRIOR LINES OF THERAPY: CARTITUDE-2 PHASE 2 STUDY

von ME Agha ; AD Cohen ; D Madduri ; et al.

Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S255- (2021)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

6
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study

von AUDEMARD-VERGER, Alexandra ; AZZI, Emmanuel ; BANNEVILLE, Béatrice ; et al.

In The Lancet Rheumatology January 2026 8(1):e33-e41
- View full text via DOI
Merkliste

7
B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE-2 RESULTS

von NWCJ van de Donk ; M Delforge ; M Agha ; et al.

HemaSphere, Vol 6, Pp 9-10 (2022)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

8
P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE

von M Mateos ; X Leleu ; E Zamagni ; et al.

HemaSphere, Vol 6, Pp 24-25 (2022)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

9
P12: TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: RETROSPECTIVE CHART REVIEW OF REAL-WORLD OUTCOMES FOR STANDARD OF CARE

von M-C Vekemans ; M Delforge ; S Anguille ; et al.

HemaSphere, Vol 6, Pp 17-18 (2022)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

10
LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma – 2-year follow-up (final analysis)

von Mateos, María-Victoria ; Weisel, Katja ; De Stefano, Valerio ; et al.

Leukemia. 38(12):2554-2560
- Zum Volltext (via ReDI)
Merkliste

11
P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY

von H Einsele ; AD Cohen ; M Delforge ; et al.

HemaSphere, Vol 6, Pp 15-15 (2022)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

12
EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders

von Nanni, Cristina ; Deroose, Christophe M. ; Balogova, Sona ; et al.

European Journal of Nuclear Medicine and Molecular Imaging. 52(1):171-192
- Zum Volltext (via ReDI)
Merkliste

13
Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma Network

von van de Donk, Niels W C J ; Moreau, Philippe ; San-Miguel, Jesús F ; et al.

In The Lancet Haematology August 2025 12(8):e635-e649
- View full text via DOI
Merkliste

14
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

15
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

von Abel, Laurent ; Aiuti, Alessandro ; Al-Muhsen, Saleh ; et al.

In Human Genetics and Genomics Advances 18 July 2024 5(3)
- View full text via DOI
Merkliste

16
Frail subgroups determine heterogeneous outcomes in older patients with NDMM – long-term follow-up of the HOVON 143 trial

von Beeker, Aart ; Bilgin, Yavuz ; de Boer, Fransien R. ; et al.

In Blood Advances July 2025
- View full text via DOI
Merkliste

17
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

von Matuozzo, Daniela ; Talouarn, Estelle ; Marchal, Astrid ; et al.

Genome Medicine. 16(1)
- Zum Volltext in PubMed Central
Merkliste

18
Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition

von Huin, Vincent ; Blum, David ; Delforge, Violette ; et al.

In Neurobiology of Disease September 2024 199
- View full text via DOI
Merkliste

19
Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

von Moreau, Philippe ; Hulin, Cyrille ; Perrot, Aurore ; et al.

In The Lancet Oncology August 2024 25(8):1003-1014
- View full text via DOI
Merkliste

20
RFC1: Motifs and phenotypes

von Delforge, V. ; Tard, C. ; Davion, J.-B. ; et al.

In Revue Neurologique May 2024 180(5):393-409
- View full text via DOI
Merkliste

21
Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial

von Delforge, Michel ; Patel, Krina ; Eliason, Laurie ; et al.

In The Lancet Haematology March 2024 11(3):e216-e227
- View full text via DOI
Merkliste

22
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

von Haas, Sylvia ; Camm, John A. ; Harald, Darius ; et al.

Clinical Research in Cardiology. 112(6):759-771
- Zum Volltext (via ReDI)
Merkliste

23
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

von AUDEMARD-VERGER, Alexandra ; AZZI, Emmanuel ; BANNEVILLE, Béatrice ; et al.

In The Lancet Rheumatology June 2023 5(6):e330-e340
- View full text via DOI
Merkliste

24
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

von Dimopoulos, Meletios A ; Richardson, Paul G ; Bahlis, Nizar J ; et al.

In The Lancet Haematology June 2022 9(6):e403-e414
- View full text via DOI
Merkliste

25
Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme

von Moerman, Alena ; Vernelen, Kris ; China, Bernard ; et al.

In Diagnostic Microbiology & Infectious Disease February 2022 102(2)
- View full text via DOI
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag